Remibrutinib in real-world clinical practice: a prospective, multi-country, non-interventional, effectiveness and safety study (REASSERT) - Local adaptation in Germany from global umbrella protocol (CLOU064A2402) First published 29/05/2026 Last updated 06/08/2026 EU PAS number:EUPAS1000001003 Study Ongoing